Top Institutions in Ophthalmology - Retinal Diseases
Leading institutions in retinal disease research utilize large-scale clinical trials, real-world data analyses, and advanced imaging techniques to study GA progression and treatment outcomes, including patient adherence to novel complement inhibitor therapies.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in retinal disease research, with extensive clinical trials and translational research programs focused on AMD and geographic atrophy, including pioneering work on complement inhibition therapies.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is renowned for its clinical expertise and research in retinal diseases, including AMD and GA, with active involvement in trials of novel therapies such as complement inhibitors and anti-VEGF agents.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a robust research program in retinal degenerations, including AMD and GA, with expertise in complement biology and patient adherence studies in intravitreal therapies.
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF has a strong focus on retinal diseases and clinical trials for AMD and GA, including studies on complement inhibition and patient-centered outcomes related to treatment adherence.
-
#5
Moorfields Eye Hospital
London, N/A
Moorfields is a leading international center for retinal disease research, with extensive clinical trial experience in AMD and GA, including complement inhibitor therapies and real-world treatment adherence studies.